Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next
10:45am, Monday, 30'th Mar 2026
The COVID-19 vaccine boom made fortunes almost overnight—and destroyed them just as fast.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:00am, Monday, 30'th Mar 2026
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development
08:00am, Monday, 30'th Mar 2026
Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical Officer Dr. Walker will continue advancing Novavax's R&D efforts with
Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know
06:46pm, Thursday, 26'th Mar 2026
In the most recent trading session, Novavax (NVAX) closed at $8.95, indicating a -4.18% shift from the previous trading day.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Monday, 23'rd Mar 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.
12:49pm, Tuesday, 17'th Mar 2026
The first severe case of the virus has been detected in New York.
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
10:01am, Tuesday, 17'th Mar 2026
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax, Inc. (NVAX) Presents at Leerink Global Healthcare Conference 2026 Transcript
06:00pm, Tuesday, 10'th Mar 2026
Novavax, Inc. (NVAX) Presents at Leerink Global Healthcare Conference 2026 Transcript
Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript
04:22pm, Tuesday, 03'rd Mar 2026
Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
10:01am, Tuesday, 03'rd Mar 2026
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
What's Going On With Novavax Stock On Friday?
02:20pm, Friday, 27'th Feb 2026
Novavax Inc. (NASDAQ: NVAX) shares are down on Friday, possibly on profit-taking after the stock rallied on Thursday following the company's announcement of its fourth-quarter and full-year 2025 finan
Novavax: The Bear Case Is Broken, But The Bull Case Needs More Proof
12:11pm, Friday, 27'th Feb 2026
Novavax (NVAX) has transitioned into a royalty-driven model, with Q4 profitability and 73% of revenue from licensing and royalties. NVAX's FY26 revenue guidance of $230M–$270M reflects cleaner, high
Novavax Stock Gains as Q4 Earnings & Sales Beat Estimates
09:30am, Friday, 27'th Feb 2026
NVAX stock jumps 17% after Q4 swings to a surprise profit on strong licensing revenues and lower costs, with sales soaring 67% year over year.
Novavax to Participate in Upcoming Investor Conferences
04:30pm, Thursday, 26'th Feb 2026
GAITHERSBURG, Md., Feb. 26, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that it will participate in the following upcoming investor conferences: TD Cowen 46 th Annual Health Ca
Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript
03:08pm, Thursday, 26'th Feb 2026
Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript
